Redox regulation in stem-like cancer cells by CD44 variant isoforms

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-10-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/onc.2012.638PMID 23334333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents.

  2012cited by this paper
• Reactive Oxygen Species in Cancer Stem Cells

  2012cited by this paper
• Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell

  2012cited by this paper
• CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma.

  2012cited by this paper
• Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.

  2012cited by this paper
• Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer

  2012cited by this paper
• Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells.

  2012cited by this paper
• Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer

  2012cited by this paper
• The convergence of radiation and immunogenic cell death signaling pathways

  2012cited by this paper
• Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

  2011cited by this paper
• The cancer stem cell: premises, promises and challenges

  2011cited by this paper
• CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

  2011cited by this paper
• Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.

  2011cited by this paper
• Selective killing of cancer cells with a small molecule targeting stress response to ROS

  2011cited by this paper
• An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype

  2011cited by this paper
• Stem Cell Marker (Nanog) and Stat-3 Signaling Promote MicroRNA-21 Expression and Chemoresistance in Hyaluronan/CD44-activated Head and Neck Squamous Cell Carcinoma Cells

  2011cited by this paper
• Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression

  2011cited by this paper
• Tumor entrained neutrophils inhibit seeding in the premetastatic lung.

  2011cited by this paper
• Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

  2011cited by this paper
• CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression.

  2011cited by this paper
• CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.

  2011cited by this paper
• Tumor-associated neutrophils: new targets for cancer therapy.

  2011cited by this paper
• Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling.

  2011cited by this paper
• Neural stem cell niches: roles for the hyaluronan-based extracellular matrix.

  2011cited by this paper
• An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition

  2010cited by this paper
• Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: Clues in the ongoing search for new tumor markers

  2010cited by this paper
• Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

  2010cited by this paper
• Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

  2010cited by this paper
• Basal Levels of eIF2α Phosphorylation Determine Cellular Antioxidant Status by Regulating ATF4 and xCT Expression*

  2009cited by this paper
• Hypoxia-inducible factors in stem cells and cancer

  2009cited by this paper
• Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition.

  2009cited by this paper
• High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Association of reactive oxygen species levels and radioresistance in cancer stem cells

  2009cited by this paper
• Tumor Necrosis Factor-α Regulates Transforming Growth Factor-β-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction*

  2009cited by this paper
• Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

  2009cited by this paper
• Reactive Oxygen Species prime Drosophila haematopoietic progenitors for differentiation

  2009cited by this paper
• ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.

  2009cited by this paper
• Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells.

  2009cited by this paper
• Cancer stem cells, hypoxia and metastasis.

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Exploring the role of cancer stem cells in radioresistance

  2008cited by this paper
• Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.

  2008cited by this paper
• Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.

  2008cited by this paper
• Molecular basis of metastasis.

  2008cited by this paper
• The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

  2008cited by this paper
• Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

  2008cited by this paper
• CD44 is of Functional Importance for Colorectal Cancer Stem Cells

  2008cited by this paper
• Direct regulation of TWIST by HIF-1α promotes metastasis

  2008cited by this paper
• The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system

  2008cited by this paper
• The x  c− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases

  2008cited by this paper
• Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.

  2008cited by this paper
• Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone

  2008cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system.

  2007cited by this paper
• Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

  2007cited by this paper
• p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis

  2007cited by this paper
• The biology of cancer stem cells.

  2007cited by this paper
• Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

  2007cited by this paper
• Cancer stem cells in solid tumors.

  2007cited by this paper
• p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis.

  2007cited by this paper
• The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

  2007cited by this paper
• Bioenergetics and the formation of mitochondrial reactive oxygen species.

  2006cited by this paper
• Cancer metastasis: building a framework.

  2006cited by this paper
• Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells

  2006cited by this paper
• Targeting of CD44 eradicates human acute myeloid leukemic stem cells

  2006cited by this paper
• A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms

  2006cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.

  2006cited by this paper
• Invasive growth: a MET-driven genetic programme for cancer and stem cells

  2006cited by this paper
• Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

  2006cited by this paper
• The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

  2006cited by this paper
• The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation.

  2006cited by this paper
• Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

  2006cited by this paper
• Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence

  2006cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• Mitochondria, oxidants, and aging.

  2005cited by this paper
• How do stem cells find their way home?

  2005cited by this paper
• CD44 attenuates metastatic invasion during breast cancer progression.

  2005cited by this paper
• CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.

  2005cited by this paper
• Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

  2005cited by this paper
• Redox Imbalance in Cystine/Glutamate Transporter-deficient Mice*

  2005cited by this paper
• CATs and HATs: the SLC7 family of amino acid transporters

  2004cited by this paper
• Mechanism and biological significance of CD44 cleavage

  2004cited by this paper
• Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness

  2004cited by this paper
• Genetically altered mice to evaluate glutathione homeostasis in health and disease.

  2004cited by this paper
• Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology

  2004cited by this paper
• CD44: From adhesion molecules to signalling regulators

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Epithelial-mesenchymal transition and its implications for fibrosis.

  2003cited by this paper
• An integrated stress response regulates amino acid metabolism and resistance to oxidative stress.

  2003cited by this paper
• Expression of the activity of cystine/glutamate exchange transporter, system x(c)(-), by xCT and rBAT.

  2003cited by this paper
• Electrophile Response Element-mediated Induction of the Cystine/Glutamate Exchange Transporter Gene Expression*

  2002cited by this paper
• CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.

  2002cited by this paper
• Absence of the CD44 gene prevents sarcoma metastasis.

  2002cited by this paper
• CD44 is required for two consecutive steps in HGF/c-Met signaling.

  2002cited by this paper
• γ‐Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver

  2002cited by this paper
• Reactive oxygen species in cell signaling.

  2000cited by this paper
• Part X • Chapter 27 – Oxidants and aging

  2000cited by this paper
• Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species*

  1999cited by this paper

• LPS Pre‐Conditioned Olfactory Ensheathing Cells Derived Extracellular Vesicle Regulate Microglia Polarization Through mir‐1224/CD44/SLC7A11 Axis Following Spinal Cord Injury

  2026cites this paper
• Mitochondrial metabolism in cancer stem cells (CSCs): molecular and diagnostic implications

  2026cites this paper
• Reactive oxygen species in cancer: Mechanistic insights and therapeutic innovations

  2025cites this paper
• CD44v, S1PR1, HER3, MET and cancer‐associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb

  2025cites this paper
• Linolenic Acid Inhibits Cancer Stemness and Induces Apoptosis by Regulating Nrf2 Expression in Gastric Cancer Cells

  2025cites this paper
• Resveratrol Enhances Sulfasalazine-induced Ferroptosis by Promoting Iron Ion Accumulation and Lipid Peroxidation in Cancer Cells

  2025cites this paper
• Gene Expression Profiling Identifies CAV1, CD44, and TFRC as Potential Diagnostic Markers and Therapeutic Targets for Multiple Myeloma

  2025cites this paper
• Cysteine addiction in drug resistant glioblastoma and therapeutic targeting with designer selenium compounds.

  2025cites this paper
• Amplification of tumor oxidative stresses with Shikonin-Fe(II) liposomal nanomedicine for enhanced anticancer treatment

  2025cites this paper
• Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer

  2025cites this paper
• Quinoa and Colonic Health: A Review of Bioactive Components and Mechanistic Insights

  2025cites this paper
• Drug Repurposing Screen Identifies Pimozide as a ROS‐Inducing Therapy With Anti‐Tumor Efficacy in HNSCC PDX Models

  2025cites this paper
• Oxidative DNA damage induced by 3,4-diOH-TAM, a tamoxifen metabolite, in relation to endometrial carcinogenesis

  2025cites this paper
• Preparation and Characterization of a Glutathione-Responsive Doxorubicin Prodrug Modified by 2-Nitrobenzenesulfonamide Group—Its Selective Cytotoxicity Toward Cells with Enhanced Glutathione Production

  2025cites this paper
• New oligomycin derivatives inhibit anchorage-independent growth of pancreatic cancer cells

  2025cites this paper
• CD44: a key regulator of iron metabolism, redox balance, and therapeutic resistance in cancer stem cells

  2025cites this paper
• Pathological and biological significance of the specific glycan, TRA-1-60, on aggressive gastric adenocarcinoma.

  2024cites this paper
• Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.

  2024cites this paper
• Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway.

  2024cites this paper
• Cystine/cysteine metabolism regulates the progression and response to treatment of triple‑negative breast cancer (Review)

  2024cites this paper
• Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance

  2024cites this paper
• Novel combinatorial autophagy inhibition therapy for triple negative breast cancers.

  2024cites this paper
• Polyunsaturated Fatty Acids in Quinoa Induce Ferroptosis of Colon Cancer by Suppressing Stemness.

  2024cites this paper
• Three Ru(II) complexes modulate the antioxidant transcription factor Nrf2 to overcome cisplatin resistance.

  2024cites this paper
• Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression

  2024cites this paper
• The amino acid transporter SLC7A11 expression in breast cancer

  2023cites this paper
• Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?

  2023cites this paper
• Roles of Virus-like particles in particularcancer vaccines

  2023cites this paper
• Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer

  2023cites this paper
• Is System xc− a Suitable Target for Tumour Detection and Response Assessment with Imaging?

  2023cites this paper
• Role of spasmolytic polypeptide-expressing metaplasia in gastric mucosal diseases.

  2023cites this paper
• Proteomics and secreted lipidomics of mouse-derived bone marrow cells exposed to a lethal level of ionizing radiation

  2023cites this paper
• Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C44Mab-108 for Immunohistochemistry

  2023cites this paper
• Tumor heterogeneity from the viewpoint of pathologists

  2023cites this paper
• Helicobacter pylori plays a key role in gastric adenocarcinoma induced by spasmolytic polypeptide-expressing metaplasia

  2023cites this paper
• Eradicating the tumor “seeds”: nanomedicines-based therapies against cancer stem cells

  2023cites this paper
• Hyaluronan and Reactive Oxygen Species Signaling—Novel Cues from the Matrix?

  2023cites this paper
• The Potential of PSMA as a Vascular Target in TNBC

  2023influential citation
• Inhibition of autophagy initiation: A novel strategy for oral squamous cell carcinomas.

  2023cites this paper
• The role of hyaluronic acid in the design and functionalization of nanoparticles for the treatment of colorectal cancer.

  2023cites this paper
• Emerging roles of inflammation-mediated endothelial–mesenchymal transition in health and disease

  2022cites this paper
• Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer

  2022cites this paper
• Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis

  2022cites this paper
• Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook

  2022cites this paper
• The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation

  2022cites this paper
• Metabolic reprograming of cancer as a therapeutic target.

  2022cites this paper
• Virus-Like Nanoparticles (VLPs) based technology in the development of breast cancer ‎vaccines‎

  2022cites this paper
• Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells

  2022cites this paper
• Amino porphyrin-peptide assemblies induce ribosome damage and cancer stem cell inhibition for an enhanced photodynamic therapy.

  2022cites this paper
• TIMP-1 Dependent Modulation of Metabolic Profiles Impacts Chemoresistance in NSCLC

  2022cites this paper
• Development of a Novel Anti−CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas

  2022cites this paper
• Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: A mini-review

  2022cites this paper
• 4-Methylumebelliferone Enhances Radiosensitizing Effects of Radioresistant Oral Squamous Cell Carcinoma Cells via Hyaluronan Synthase 3 Suppression

  2022cites this paper
• Application of cancer stem cells in improving therapeutics

  2021cites this paper
• The role of CD44 in cancer chemoresistance: a concise review.

  2021cites this paper
• Reactive Oxygen Species-Dependent Signaling Pathways in Cancer Stem Cells

  2021cites this paper
• Cysteine Metabolism in Cancer Progression and Therapy Resistance

  2021cites this paper
• The glycocalyx and immune evasion in cancer

  2021cites this paper
• Yin-Yang of Oxidative Stress in Pancreatic Cancers

  2021cites this paper
• Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids.

  2021cites this paper
• Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome

  2021cites this paper
• Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions

  2021cites this paper
• Fluorescent nanodiamond – hyaluronate conjugates for target-specific molecular imaging

  2021cites this paper
• Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome

  2021cites this paper
• Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers

  2021cites this paper
• Simple Fluorescence Assay for Cystine Uptake via the xCT in Cells Using Selenocystine and a Fluorescent Probe.

  2021cites this paper
• Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation

  2021cites this paper
• Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma

  2021cites this paper
• Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma

  2021cites this paper
• Gastric Cancer Stem Cells: A Glimpse on Metabolic Reprogramming

  2021cites this paper
• A Simple Fluorescence Assay for Cystine Uptake via the xCT in Cells using Selenocystine and a Fluorescent Probe

  2021cites this paper
• Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF‐kB signaling pathways synergistically

  2021cites this paper
• Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer

  2021cites this paper
• Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche

  2021cites this paper
• Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients

  2021cites this paper
• Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.

  2021cites this paper
• PKCα Inhibition as a Strategy to Sensitize Neuroblastoma Stem Cells to Etoposide by Stimulating Ferroptosis

  2021cites this paper
• CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression

  2021cites this paper
• Amino Acid Transporters on the Guard of Cell Genome and Epigenome

  2021cites this paper
• Amlodipine and Verapamil, Voltage-Gated Ca2+ Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem Cells

  2021cites this paper
• Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin

  2020cites this paper
• The Role of Metaplasia During Gastric Regeneration.

  2020cites this paper
• CD44 expression enhances chemoresistance and implies occult micrometastases after conversion hepatectomy for initially unresectable colorectal liver metastases.

  2020cites this paper
• Multiple Dynamics in Tumor Microenvironment Under Radiotherapy.

  2020cites this paper
• Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer

  2020cites this paper
• Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer

  2020cites this paper
• STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects

  2020cites this paper
• Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines

  2020influential citation
• Phenolic compounds from Mediterranean foods as nutraceutical tools for the prevention of cancer: The effect of honey polyphenols on colorectal cancer stem-like cells from spheroids.

  2020cites this paper
• Functional analysis of CD44 variants and xCT in canine tumours

  2020cites this paper
• Tumor Microenvironment: State of the Science

  2020cites this paper
• Cancer stem cell marker-positive tumour nests in intrahepatic cholangiocarcinoma are related to epithelial type CD1a-positive dendritic cell infiltration and to high Sox9 expression

  2020cites this paper
• DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia

  2020cites this paper
• Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact

  2020cites this paper
• 18F-Labeled dihydromethidine: positron emission tomography radiotracer for imaging of reactive oxygen species in intact brain.

  2020cites this paper
• Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

  2020cites this paper
• Pyridoxine enhances chemo-responsiveness of breast cancer stem cells via redox reconditioning.

  2020cites this paper
• Breast cancer stem cell antigens as targets for immunotherapy.

  2020cites this paper
• Dual Fluorescence Splicing Reporter Minigene Identifies an Antisense Oligonucleotide to Skip Exon v8 of the CD44 Gene

  2020cites this paper
• Head and neck cancer management and cancer stem cells implication

  2019cites this paper